Neuroendocrine differentiation of prostate cancer: a review.
about
Prostate Cancer Stem Cells: Research AdvancesEpithelial-mesenchymal transition in prostate cancer: an overview.Regulation of c-Myc expression by the histone demethylase JMJD1A is essential for prostate cancer cell growth and survival.Identifying cancer origin using circulating tumor cells.Systemic alkalinisation delays prostate cancer cell progression in TRAMP mice.Chromogranin A as a valid marker in oncology: Clinical application or false hopes?SSX2 regulates focal adhesion but does not drive the epithelial to mesenchymal transition in prostate cancer.FOXA1 inhibits prostate cancer neuroendocrine differentiation.Emerging Variants of Castration-Resistant Prostate Cancer.Inhibition of FOXC2 restores epithelial phenotype and drug sensitivity in prostate cancer cells with stem-cell propertiesInduction of Neuroendocrine Differentiation in Prostate Cancer Cells by Dovitinib (TKI-258) and its Therapeutic Implications.Chemopreventive Potential of Ethanolic Extracts of Luobuma Leaves (Apocynum venetum L.) in Androgen Insensitive Prostate Cancer.Potential therapeutic effect of epigenetic therapy on treatment-induced neuroendocrine prostate cancer.MYC regulates ductal-neuroendocrine lineage plasticity in pancreatic ductal adenocarcinoma associated with poor outcome and chemoresistance.Autocrine, paracrine and necrotic NMDA receptor signalling in mouse pancreatic neuroendocrine tumour cells.Reduction of two histone marks, H3k9me3 and H3k27me3 by epidrug induces neuroendocrine differentiation in prostate cancer.Calcium and Nuclear Signaling in Prostate Cancer.The Use of Biomarkers in Prostate Cancer Screening and Treatment.Roles of Alternative RNA Splicing of the Bif-1 Gene by SRRM4 During the Development of Treatment-induced Neuroendocrine Prostate Cancer.
P2860
Q26998435-404B8127-754E-4FA3-AAC0-2CAE3D05ABFBQ33798864-2C018FCD-06B9-4AB6-85A4-49A0D71CCF95Q36590632-3E147B5D-DF74-490C-8164-3AEFB61A893EQ37013321-D155EB28-729E-4830-AA49-6DE1C27E202AQ38720922-C8055501-0DC6-4079-82E4-9917A1860374Q38843394-03935C43-A675-4685-9DD0-D07CE59F0255Q38856316-4C3AA54B-3835-422B-AFFF-C873F61AFAD4Q38893882-F1B82280-36F3-482A-91B9-62E90C1030D0Q39210257-6A302B21-049B-4F3C-97B1-072FCD2A91ADQ42078200-35EEED19-14A2-430F-875A-C4256D23F54FQ42108610-223D4141-F4C2-4BF1-925A-9574F4C9C5AFQ42368217-FE43A26C-9A40-44AA-BD43-8AFC9900EEE1Q43623151-48F21D78-8311-486D-B8FB-23AF320E6856Q47111931-042DC1BE-89A8-4BE6-90EC-0ED0E1B35B64Q47142464-FC1426EA-E910-4554-A25E-1FFA036B859CQ48125169-A9D4CC96-CB2F-4254-83EA-9C7D933EDBFDQ52578386-837D5376-491C-41F1-BA4D-9A27C1BAB7ABQ52689045-E581C035-E924-4669-94DF-57B784D563F4Q55291143-496041F2-E997-451F-A53A-5532409F1678
P2860
Neuroendocrine differentiation of prostate cancer: a review.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Neuroendocrine differentiation of prostate cancer: a review.
@en
type
label
Neuroendocrine differentiation of prostate cancer: a review.
@en
prefLabel
Neuroendocrine differentiation of prostate cancer: a review.
@en
P2093
P2860
P1476
Neuroendocrine differentiation of prostate cancer: a review.
@en
P2093
Kate Poropatich
Rajen Goyal
Vamsi Parimi
Ximing J Yang
P2860
P304
P577
2014-12-09T00:00:00Z